Pediatric Medicines: Global Markets

Dec 2019| PHM170B| BCC Publishing

Report Highlights

The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.

Report Includes

  • 55 tables
  • An overview of the global markets for pediatric medicines within the pharmaceutical industry
  • Analyses of the global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Discussion on market drivers, off-label use, novel formulations and areas of unmet clinical need and emerging countries
  • Market analysis for therapeutic fields including neonates and paediatrics childhood cancers, CNS disorders, infectious diseases, immune inflammatory diseases, metabolic diseases, respiratory conditions, vaccinations
  • Regulatory environment and incentives for pediatric development
  • Profiles of major companies of the industry, including Abbott Laboratories, GlaxoSmithKline, Novartis AG, Sanofi and Vertex Pharmaceuticals Inc.

Report Scope

This new report on pediatric medicine will provide a brief overview on the current status of the industry and recent developments. It presents the changing environment in terms of new legislation and implementation of global pediatric plans. The report analyzes market trends and identifies key therapeutic and geographical challenges and rising opportunities in the developed and developing world. Finally, the report provides insights on how all stakeholders have an essential interest in prioritizing pediatric drug development targets and improving access to safe and effective medicines to children across the globe.

Analyst Credentials

Dr. C. L. Barton has more than 10 years’ practical pharmaceutical research experience with a leading pharmaceutical company and has served as a pan-European pharmaceutical analyst with a European bank. Dr. C.L. Barton Ltd. aims to provide independent, tailor-made, pharmaceutical thematic research to investment houses. Research reports combine independent scientific analysis with patient- and prescription-based models to forecast the potential sales growth of key developmental drugs and to isolate the key drivers within the pharmaceutical sector. For further information, visit

Dr. Bianca Piachaud-Moustakis has more than 15 years of experience as a writer and research analyst specializing in pharmaceutical and healthcare intelligence and has worked for a number of market intelligence providers in the U.K. She has a broad range of writing experience ranging from international academic and practitioner journals, to producing market intelligence reports and short articles. Areas of specialization include pharmaceuticals, healthcare, diagnostics, drug delivery systems, emerging research and development technologies and pharmaceutical regulation.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesMember Price
Full Report: Pediatric Medicines: Global Markets169Free
Chapter- 1: Introduction to Pediatric Medicine3Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Pediatric Market Dynamics19Free
Chapter- 4: Regulation of Pediatric Medicine23Free
Chapter- 5: Challenges of Developing Pediatric Medicine22Free
Chapter- 6: Opportunities for Pediatric Medicine45Free
Chapter- 7: Future Outlook for Pediatric Medicine 13Free
Chapter- 8: Company Profiles 22Free
Chapter- 9: Appendix: Acronyms3Free
Published - Oct-2014| Analyst - Dr. Cheryl Lee Barton| Code - PHM170A

Report Highlights

The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Report Includes

  • An overview of the global market for pediatric medicines.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • Discussion on market drivers and inhibitors, and the area of unmet clinical need.
  • Information on the regulatory environment and impacts of government.
  • Details pertaining to the barriers to entry for pediatric medicines.
  • Market analysis for therapeutic fields including childhood cancers, CNS disorders, inflammatory diseases, metabolic diseases, respiratory conditions, vaccinations, and viral infections.

Pediatric Medicines: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries